Key result
The acute phase of aseptic meningitis was associated with significantly higher CSF interferon-alpha levels (<10 to 25.5 IU/ml) compared to the convalescent phase.
Observational (n=29)
In acute enteroviral CNS infections, IFN-alpha likely plays a key role in curbing local viral spread during the acute phase, while neutralizing antibodies play a smaller role in recovery.
Supports IFN-alpha's role in acute enteroviral CNS defense; hypothesis-generating for immunomodulatory strategies before clinical consideration.
Cerebrospinal fluids (CSFs) and sera from 20 patients with echovirus 30 (E 30) meningitis, 4 patients with enterovirus 71 (EV 71) meningitis, and 5 patients with acute aseptic meningitis (AM) of unknown etiology were investigated at the acute and the convalescent phases of the disease to elucidate the roles of neutralizing antibody (NT) and interferon-alpha (IFN-alpha) in the central nervous system (CNS) in cases of AM in humans. Viruses were isolated from the CSFs at the acute phase of AM, but not at the convalescent phase. There was a fourfold or greater rise in NT titer between paired sera to E 30 or EV 71 but only a slight rise between paired CSFs. IFN-alpha was detected in the CSFs ranging from less than 10 to 25.5 IU/ml but not in the sera, and the IFN-alpha level in the CSF was significantly higher in the acute phase than in the convalescent phase. These results suggest that in cases of acute enteroviral infections in the CNS, NT plays only a small role in the recovery from AM, and IFN-alpha plays a direct or indirect role in curbing the local spread of the virus and eliminating the virus from the CNS at the acute phase of AM.
No takes yet. Share an insight, caveat, or question.
Ichimura et al. (1985) conducted an observational in Acute aseptic meningitis (n=29). Acute phase of aseptic meningitis vs. Convalescent phase was evaluated on Neutralizing antibody (NT) titer and interferon-alpha (IFN-alpha) levels in CSF and sera. The acute phase of aseptic meningitis was associated with significantly higher CSF interferon-alpha levels (<10 to 25.5 IU/ml) compared to the convalescent phase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: